{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T18:22:46Z","timestamp":1745864566645},"reference-count":55,"publisher":"Consilium Medicum","issue":"11","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>The lecture is devoted to the analysis of the state-of-the-art of the impact of genetic diversity of human immunodeficiency (HIV) viruses on the pattern of infection and the efficiency of antiretroviral therapy (ART). It provides brief information on the origin and evolution of HIV and on the current classification of their genetic variants. The molecular epidemiological situation of HIV infection in Russia and nearby states and the major molecular HIV variants that are dominant in these countries, as well as their origin and prevalence trends are characterized. How the diversity of HIV can affect the efficiency of diagnosis, the transmission of the virus, and the pattern of HIV pathogenesis are briefly reviewed. The comparative data available in the world\u2019s scientific literature on these topics are given. More detailed attention is given to the possible causes of varying therapeutic effects against different HIV subtypes, as well as to the specific features of the formation and phenotyping manifestation of ART drug resistance mutations. There is evidence for the necessity of forming a unified follow-up system for treated HIV-infected patients during ART scaling, including in an effort to evaluate the impact of the specific features of the HIV genome on the efficiency of treatment regimens used in Russia.<\/jats:p>","DOI":"10.17116\/terarkh20168811103-111","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T10:58:49Z","timestamp":1481799529000},"page":"103-111","source":"Crossref","is-referenced-by-count":5,"title":["Genetic diversity of human immunodeficiency viruses and antiretroviral therapy"],"prefix":"10.26442","volume":"88","author":[{"given":"M R","family":"Bobkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.12.001"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br med bull. 2001;58:19-42.","DOI":"10.1093\/bmb\/58.1.19"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835461b5"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000137"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006841"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"B\u00e1rtolo I, Taveira N. HIV-1 Diversity and Its Implications in Diagnosis, Transmission, Disease Progression, and Antiretroviral Therapy. In: Caliskan M, ed. Genetic Diversity in Microorganisms. InTech; 2012.","DOI":"10.5772\/34131"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00985-07"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000331993"},{"key":"ref9","unstructured":"Peeters M, D\u2019Arc M, Delaporte E. Origin and diversity of human retroviruses. AIDS Rev. 2014;16(1):23-34."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/481314"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2015.05.003"},{"key":"ref12","unstructured":"Bobkova M. Current status of HIV-1 diversity and drug resistance monitoring in the former USSR. AIDS Rev. 2013;15(4):204-212."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20177"},{"key":"ref14","unstructured":"\u0411\u043e\u0431\u043a\u043e\u0432\u0430 \u041c.\u0420., \u0411\u0443\u0440\u0430\u0432\u0446\u043e\u0432\u0430 \u0415.\u0412., \u0421\u0443\u0445\u0430\u043d\u043e\u0432\u0430 \u0410.\u041b., \u041e\u043b\u044c\u0445\u043e\u0432\u0441\u043a\u0438\u0439 \u0418.\u0410., \u0411\u043e\u0431\u043a\u043e\u0432 \u0410.\u0424., \u041f\u043e\u043a\u0440\u043e\u0432\u0441\u043a\u0438\u0439 \u0412.\u0412.. \u041f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u0435 \u0442\u0435\u0441\u0442-\u0441\u0438\u0441\u0442\u0435\u043c\u044b Amplicor HIV-1 \u0434\u043b\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0438 \u0412\u0418\u0427-\u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 \u0443 \u043d\u043e\u0432\u043e\u0440\u043e\u0436\u0434\u0435\u043d\u043d\u044b\u0445 \u0434\u0435\u0442\u0435\u0439 \u0432 \u0420\u043e\u0441\u0441\u0438\u0438: \u043f\u0435\u0440\u0432\u044b\u0435 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b (2001\u20142002 \u0433\u0433.). \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043b\u0430\u0431\u043e\u0440\u0430\u0442\u043e\u0440\u043d\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430. 2003;6:49-53."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bogh M, Machuca R, Gerstoft J, Pedersen C, Obel N, Kvinesdal B, Nielsen H, Nielsen C. Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test. J Clin Virol. 2001;20(3):149-153.","DOI":"10.1016\/S1386-6532(00)00147-5"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Obaro SK, Losikoff P, Harwell J, Pugatch D. Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A\/G. Pediatr Infect Dis J. 2005;24(2):183-184.","DOI":"10.1097\/01.inf.0000151040.57772.40"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.05.013"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Hudgens MG, Longini IM, Jr., Vanichseni S, Hu DJ, Kitayaporn D, Mock PA, Halloran ME, Satten GA, Choopanya K, Mastro TD. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol. 2002;155(2):159-168.","DOI":"10.1093\/aje\/155.2.159"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328330cc08"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00218-07"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000060412.18106.d4"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/431514"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/s0001-37652006000100011"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b7dca"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-13-4"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31824a0628"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/605284"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2955-08.2008"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024130"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1086\/527416"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"De Wit S, Boulme R, Poll B, Schmit JC, Clumeck N. Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients. AIDS (London, England). 2004;18(17):2330-2331.","DOI":"10.1097\/00002030-200411190-00016"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Frater AJ, Dunn DT, Beardall AJ, Ariyoshi K, Clarke JR, McClure MO, Weber JN. Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS (London, England). 2002;16(8):1139-1146.","DOI":"10.1097\/00002030-200205240-00007"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1086\/598502"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir669"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086239"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328348065a"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0239"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1697"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir686"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Tuaillon E, Gueudin M, Lemee V, Gueit I, Roques P, Corrigan GE, Plantier JC, Simon F, Braun J. Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups. J AIDS. 2004;37(5):1543-1549.","DOI":"10.1097\/00126334-200412150-00001"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222366699"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1086\/431197"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.08.006"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00495-16"},{"key":"ref45","unstructured":"\u0411\u043e\u0431\u043a\u043e\u0432\u0430 \u041c.\u0420. \u041b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f \u0443\u0441\u0442\u043e\u0439\u0447\u0438\u0432\u043e\u0441\u0442\u044c \u0412\u0418\u0427. \u041c.: \u0427\u0435\u043b\u043e\u0432\u0435\u043a; 2014."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037983"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283636179"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2217\/hiv.09.40"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000485"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00829-10"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06079-11"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr582"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833cf265"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1443"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2159-2165.2004"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32113\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:43:52Z","timestamp":1634089432000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/32113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,15]]}},"URL":"https:\/\/doi.org\/10.17116\/terarkh20168811103-111","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}